Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Charoen Pokphand Indonesia Tbk (CPIN) vs UBC Medical Indonesia Tbk. (LABS)

Charoen Pokphand Indonesia TbkTrading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Charoen Pokphand Indonesia Tbk dan UBC Medical Indonesia Tbk.: Charoen Pokphand Indonesia Tbk diperdagangkan di Rp3.070 (kapitalisasi pasar 50,83 T, volume 24 jam 11,89 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Charoen Pokphand Indonesia Tbk jauh lebih besar — sekitar 86,9× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Charoen Pokphand Indonesia Tbk lebih aktif diperdagangkan (11,89 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.

CPINLABS
Kapitalisasi Pasar
50,83 T584,6 M
Volume
11,89 jt817,3 rb
Lot
118,87 rb8,17 rb
Perputaran
36,7 M120,01 jt
Harga Rata-rata
3.087,87146,84
Nilai Transaksi
36,7 M120,01 jt
Harga Ekuilibrium Indikatif
3.070146
Volume Ekuilibrium Indikatif
13,65 rb59

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

CPIN
Lihat detail
LABS
Lihat detail

Tentang Charoen Pokphand Indonesia Tbk

PT Charoen Pokphand Indonesia Tbk (the Company) was established in Indonesia within the framework of Foreign Investment Law No. 1 year 1967 based on Notarial Deed No. 6 dated January 7, 1972 of Drs. Gde ngurah Rai, S.H. PT Charoen Pokphand Indonesia (CPI) established by CP Overseas Investment Co. Ltd., Hongkong. CPI is one of Indonesia leading agribusiness companies, with a clear focus on the formulation and production of poultry feed and the breeding of top quality poultry stock for Indonesian market. CPI is supported by expertise and experience of the established Charoen Pokphand Group of Thailand. The company has a fabrication plant, research and development facilities and breeding centers.

Selengkapnya di halaman CPIN

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS